Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Equity Ratio (2018 - 2025)

Volitionrx filings provide 11 years of Equity Ratio readings, the most recent being 5.16 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 94.63% to 5.16 in Q4 2025 year-over-year; TTM through Dec 2025 was 5.16, a 94.63% decrease, with the full-year FY2025 number at 5.16, down 94.63% from a year prior.
  • Equity Ratio hit 5.16 in Q4 2025 for Volitionrx, up from 5.57 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.76 in Q2 2021 to a low of 5.57 in Q3 2025.
  • Median Equity Ratio over the past 5 years was 0.17 (2022), compared with a mean of 1.2.
  • Biggest five-year swings in Equity Ratio: grew 10.84% in 2023 and later plummeted 1043.54% in 2024.
  • Volitionrx's Equity Ratio stood at 0.64 in 2021, then crashed by 126.51% to 0.17 in 2022, then plummeted by 82.37% to 0.31 in 2023, then crashed by 750.13% to 2.65 in 2024, then plummeted by 94.63% to 5.16 in 2025.
  • The last three reported values for Equity Ratio were 5.16 (Q4 2025), 5.57 (Q3 2025), and 3.8 (Q2 2025) per Business Quant data.